Larke, Jules A.
Heiss, Britta E.
Ehrlich, Amy M.
Taft, Diana H.
Raybould, Helen E.
Mills, David A.
Slupsky, Carolyn M.
Funding for this research was provided by:
National Institutes of Health (5T32AI060555, F32HD093185, AT008759, AT008759)
National Institute of Food and Agriculture (1021411)
Article History
Received: 7 November 2022
Accepted: 14 July 2023
First Online: 28 August 2023
Declarations
:
: Animals were maintained in accordance with IACUC Protocol 21900 approved by the Institutional Animal Care and Use Committee of University of California, Davis.
: N/A.
: D.A.M. is a co-founder of Evolve Biosystems, a company focused on diet-based manipulation of the gut microbiota, and BCD Biosciences, a company advancing novel bioactive glycans. Neither Evolve Biosystems or BCD Biosciences had a role in the conceptualization, design, data collection, analysis, interpretation of data, preparation and writing of this manuscript, or in the decision to submit the paper for publication.